MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1300 participants.

Also called NCT05487612

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05487612
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada, Germany, Greece, Italy, Türkiye, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05487612. Randomized; single masking; primary purpose treatment. Start 2022-05-26 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
Acronym
MiECS
Condition
Aortic Valve Stenosis
Condition
Extracorporeal Circulation; Complications
Intervention (Device)
Minimal Invasive Extracorporeal Circulation
Intervention (Device)
Conventional cardiopulmonary bypass
Lead sponsor
Aristotle University Of Thessaloniki (class: other)
Collaborator
Minimal Invasive Extracorporeal Technologies International Society (MiECTiS) (class: not stated)

Record details

Record id
cardio:ct-nct05487612
Content hash
27d4a7ffb4700d83e398915b41b6cd3d781701edf5cd1c0413fc76656957f175